trending Market Intelligence /marketintelligence/en/news-insights/trending/xAVoGdvDhDEuMxQ-WsZIww2 content esgSubNav
In This List

Rexahn Pharmaceuticals transfers listing to Nasdaq Capital Market

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Rexahn Pharmaceuticals transfers listing to Nasdaq Capital Market

Rexahn Pharmaceuticals Inc. said it will transfer its listing from the NYSE American exchange to the Nasdaq Capital Market.

The Rockville, Md.-based biotechnology company, which develops treatments for cancer, expects to start trading on Nasdaq under the symbol REXN on or about June 10.

The company's stock will continue to trade on the NYSE American under the symbol RNN until the transfer is completed.